Aflac (NYSE:AFL) Director Joseph Moskowitz Sells 600 Shares of Stock

Aflac Incorporated (NYSE:AFL) Director Joseph Moskowitz sold 600 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $124.10, for a total transaction of $74,460.00. Following the transaction, the director owned 32,710 shares of the company’s stock, valued at approximately $4,059,311. This trade represents a 1.80% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Aflac Price Performance

NYSE:AFL traded down $0.58 during trading hours on Wednesday, hitting $120.49. 176,801 shares of the stock were exchanged, compared to its average volume of 2,352,761. The firm’s fifty day moving average price is $121.06 and its 200 day moving average price is $115.59. Aflac Incorporated has a 52-week low of $103.80 and a 52-week high of $130.22. The company has a market cap of $61.33 billion, a P/E ratio of 12.90, a P/E/G ratio of 1.96 and a beta of 0.60. The company has a current ratio of 0.12, a quick ratio of 0.11 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last issued its quarterly earnings results on Thursday, August 6th. The financial services provider reported $1.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.76 by ($0.01). Aflac had a return on equity of 13.27% and a net margin of 26.91%.The firm had revenue of $4.22 billion during the quarter, compared to analyst estimates of $4.11 billion. During the same period in the prior year, the firm earned $1.78 earnings per share. The business’s revenue was down 1.0% on a year-over-year basis. As a group, equities research analysts anticipate that Aflac Incorporated will post 7.05 EPS for the current fiscal year.

Aflac Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Wednesday, August 19th will be paid a dividend of $0.61 per share. This represents a $2.44 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Wednesday, August 19th. Aflac’s payout ratio is 26.15%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Brighton Jones LLC grew its holdings in shares of Aflac by 64.4% in the fourth quarter. Brighton Jones LLC now owns 14,570 shares of the financial services provider’s stock valued at $1,507,000 after purchasing an additional 5,708 shares during the period. Bison Wealth LLC raised its stake in Aflac by 4.3% during the fourth quarter. Bison Wealth LLC now owns 4,402 shares of the financial services provider’s stock worth $455,000 after purchasing an additional 183 shares during the period. WINTON GROUP Ltd acquired a new position in Aflac in the 2nd quarter valued at about $280,000. Sei Investments Co. boosted its holdings in Aflac by 11.2% in the 2nd quarter. Sei Investments Co. now owns 150,334 shares of the financial services provider’s stock valued at $15,854,000 after purchasing an additional 15,105 shares during the last quarter. Finally, Main Street Financial Solutions LLC raised its position in shares of Aflac by 1.6% during the 2nd quarter. Main Street Financial Solutions LLC now owns 11,953 shares of the financial services provider’s stock valued at $1,261,000 after buying an additional 192 shares during the period. Institutional investors and hedge funds own 67.44% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Wells Fargo & Company increased their target price on shares of Aflac from $111.00 to $120.00 and gave the company an “equal weight” rating in a research report on Thursday, July 9th. Piper Sandler reaffirmed an “overweight” rating and set a $138.00 price objective (up from $130.00) on shares of Aflac in a research note on Monday. Morgan Stanley raised their target price on shares of Aflac from $120.00 to $125.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 21st. UBS Group restated a “neutral” rating and set a $124.00 target price (up from $114.00) on shares of Aflac in a report on Wednesday, July 8th. Finally, Jefferies Financial Group restated a “hold” rating and issued a $108.00 price target (up from $100.00) on shares of Aflac in a research report on Friday, July 10th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $117.58.

More Aflac News

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: Keefe, Bruyette & Woods raised its price target for Aflac from $120 to $125 while maintaining a “market perform” rating, suggesting some analysts see limited upside from current levels. Benzinga analyst update
• Positive Sentiment: Zacks identified Aflac as one of several accident and health insurers positioned to benefit from rising underwriting exposure and increased digitalization. These industry trends could support future premium growth, although medical-cost inflation remains a risk. Zacks accident and health insurers outlook
• Neutral Sentiment: Wells Fargo maintained a “hold” rating and a $120 price target, citing Aflac’s solid competitive positioning but also modest growth prospects and concerns about mergers-and-acquisitions-related capital allocation. TipRanks Wells Fargo rating
• Neutral Sentiment: Aflac launched a social-emotional learning initiative with educator Ron Clark and DonorsChoose, expanding its community and brand-building efforts for children affected by cancer and blood disorders. The announcement is unlikely to materially affect near-term earnings. Aflac social-emotional learning initiative
• Negative Sentiment: JPMorgan lowered its price target from $117 to $116 and kept a “neutral” rating, reinforcing the view that upside may be limited.
• Negative Sentiment: Dowling & Partners reduced its 2026 earnings-per-share estimate to $7.00 from $7.05. The cut, combined with Aflac’s recent quarterly EPS miss and year-over-year revenue decline, adds pressure to the near-term outlook.
• Negative Sentiment: Broader commentary remains cautious because Aflac has lagged the S&P 500 and analysts see only modest growth. A separate announcement about “AFL Integria” concerns a different fiber-optics company, not Aflac Incorporated.

About Aflac

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.